Constraint-Induced (CI) Movement Therapy for Progressive Multiple Sclerosis (MS)

National Multiple Sclerosis Society

Status and phase: Completed; Phase 1

Conditions: Multiple Sclerosis

Treatments: Behavioral: Constraint-Induced Movement Therapy

Study type: Interventional

Funder types: Other

Identifiers

NCT00695084

PP1395

CIMSTrial

Details and patient eligibility

About

This trial will evaluate whether progressive multiple sclerosis associated with hemiparesis may benefit from Constraint-Induced Movement Therapy.

Full description

Constraint-Induced Movement Therapy was developed to treat stroke hemiparesis. Due to the similarity between multiple sclerosis and stroke in terms of chronic motor deficit, this trial will attempt to determine whether multiple sclerosis may benefit similarly from Constraint-Induced Movement Therapy.

Enrollment: 7 patients

Sex: All

Ages: 21 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Chronic upper extremity motor deficit due to multiple sclerosis

Exclusion criteria

• Relapse within 3 months of planned enrollment.

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

7 participants in 1 patient group

1

Experimental group

Description:

Treatment with Constraint-Induced Movement Therapy

Treatment:

Behavioral: Constraint-Induced Movement Therapy